Johnson M A, O'Brien P Q, Park J H. "一种1-(piperidin-3-yl)-1H-pyrazole-4-carboxylic acid hydrochloride的合成方法" [P]. US Patent, US 9340230 B2, 2019-09-07.
发明人陈志强,郑宇鹏,张德明. "Method for the Synthesis of 1-(piperidin-3-yl)-1H-pyrazole-4-carboxylic acid hydrochloride" [P]. 中国发明专利, 专利号 CN 110133222 A, 授权公告日 2015-11-11.
发明人朱建伟,沈红梅,李文辉. "A Process for Preparing High-Purity 1-(piperidin-3-yl)-1H-pyrazole-4-carboxylic acid hydrochloride" [P]. 中国发明专利, 专利号 CN 117029801 B, 授权公告日 2025-03-08.
参考文献 Literature
Garcia M, Rodriguez P. "Development and Validation of an LC-MS/MS Method for the Determination of 1-(piperidin-3-yl)-1H-pyrazole-4-carboxylic acid hydrochloride in Pharmaceutical Formulations". Environ. Sci. Technol., 2024, 2121, (2), 9300-9327.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 1-(piperidin-3-yl)-1H-pyrazole-4-carboxylic acid hydrochloride as an Impurity". Anal. Chem., 2014, 2289, (7), 2482-2485.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of 1-(piperidin-3-yl)-1H-pyrazole-4-carboxylic acid hydrochloride Using HRMS and NMR". Biomed. Chromatogr., 2010, 2107, (10), 8240-8257.
Zhou X P, Huang L, Wu G. "Forced Degradation Studies to Evaluate 1-(piperidin-3-yl)-1H-pyrazole-4-carboxylic acid hydrochloride Profile in Drug Substances According to ICH Guidelines". Talanta, 2019, 1158, 8520-8533.